198 related articles for article (PubMed ID: 17659325)
21. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
22. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
24. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer.
Nicklin J; Janda M; Gebski V; Jobling T; Land R; Manolitsas T; McCartney A; Nascimento M; Perrin L; Baker JF; Obermair A;
Int J Cancer; 2012 Aug; 131(4):885-90. PubMed ID: 21918977
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen-125 (CA-125) in carcinoma of the endometrium.
Yu B; Xu PZ; Wang QW; Zhou H; Zhou HX
J Int Med Res; 2009; 37(3):878-83. PubMed ID: 19589273
[TBL] [Abstract][Full Text] [Related]
26. Serum biomarker profiles as diagnostic tools in lung cancer.
Nolen BM; Langmead CJ; Choi S; Lomakin A; Marrangoni A; Bigbee WL; Weissfeld JL; Wilson DO; Dacic S; Siegfried JM; Lokshin AE
Cancer Biomark; 2011-2012; 10(1):3-12. PubMed ID: 22297547
[TBL] [Abstract][Full Text] [Related]
27. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
28. Discovery of biomarkers for endometrial cancer: current status and prospects.
Rižner TL
Expert Rev Mol Diagn; 2016 Dec; 16(12):1315-1336. PubMed ID: 27817223
[TBL] [Abstract][Full Text] [Related]
29. DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer.
Di Cello A; Di Sanzo M; Perrone FM; Santamaria G; Rania E; Angotti E; Venturella R; Mancuso S; Zullo F; Cuda G; Costanzo F
Tumour Biol; 2017 Jun; 39(6):1010428317705746. PubMed ID: 28618925
[TBL] [Abstract][Full Text] [Related]
30. Shed membrane fragment-associated markers for endometrial and ovarian cancers.
Taylor DD; Lyons KS; Gerçel-Taylor C
Gynecol Oncol; 2002 Mar; 84(3):443-8. PubMed ID: 11855885
[TBL] [Abstract][Full Text] [Related]
31. OVX1 as a marker for early stage endometrial carcinoma.
Xu FJ; Yu YH; Daly L; Anselmino L; Hass GM; Berchuck A; Rodriguez GC; Soper JT; Clarke-Pearson DL; Hollis D
Cancer; 1994 Apr; 73(7):1855-8. PubMed ID: 8137210
[TBL] [Abstract][Full Text] [Related]
32. Serum protein markers for early detection of ovarian cancer.
Mor G; Visintin I; Lai Y; Zhao H; Schwartz P; Rutherford T; Yue L; Bray-Ward P; Ward DC
Proc Natl Acad Sci U S A; 2005 May; 102(21):7677-82. PubMed ID: 15890779
[TBL] [Abstract][Full Text] [Related]
33. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
[TBL] [Abstract][Full Text] [Related]
34. Best serum biomarker combination for ovarian cancer classification.
Song HJ; Yang ES; Kim JD; Park CY; Kyung MS; Kim YS
Biomed Eng Online; 2018 Nov; 17(Suppl 2):152. PubMed ID: 30396341
[TBL] [Abstract][Full Text] [Related]
35. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
36. Validation of serum biomarkers for detection of early-stage ovarian cancer.
Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
[TBL] [Abstract][Full Text] [Related]
37. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
[TBL] [Abstract][Full Text] [Related]
38. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
39. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
40. Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience.
Wen YH; Chang PY; Hsu CM; Wang HY; Chiu CT; Lu JJ
Clin Chim Acta; 2015 Oct; 450():273-6. PubMed ID: 26344337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
